Caroline Bleakley

I didn't choose ADHD as my speciality; it found me, and I'm incredibly grateful for that.

When I completed my medical training at the University of Leeds in 1990, neurodisability wasn't yet its own independent speciality. My early career took me through adult cardiology and emergency medicine, both for adults and children. I eventually became a qualified GP in 1995, drawing a solid foundation in understanding physical and mental health. However, a year of paediatric training during my vocational training scheme illuminated my true calling.

During my journey, I had the privilege of meeting Dr. Val Harpin, an inspiring paediatrician and mentor who pioneered ADHD assessment and treatment in the 90s. Dr Harpin's involvement in research and education, along with her founding of the Sheffield ADHD service and contribution to the UK ADHD NICE guidance in 2008, captivated me.

I cherished the unique perspective on family life and the complexity of ADHD coexisting with other conditions. For nearly 25 years, I've been a part of the neurodevelopmental paediatrics team at Sheffield Children's NHS Foundation Trust, where my role evolved as ADHD transcended from a childhood condition to an ongoing concern in young adults.

I collaborated with adult psychiatry colleagues in joint transition clinics, participated in pharmaceutical studies, and gained insight into the significance of measurement-based clinical care for ADHD services.

My involvement expanded to being a UK medical advisor to pharmaceutical companies, attending global conferences, and engaging with experts in the ADHD field. My passion for ADHD education remains, as I continue my clinical work as a Neurodisability Paediatrician and lead paediatrician for the Sheffield Children's NHS Foundation Trust ADHD service.

I had the honour of presenting the updated NICE NG 87 ADHD guidelines in March 2018 at the Royal College of Paediatrics conference in Glasgow. My commitment to evidence-based practices, continuous learning, and knowledge-sharing remains unwavering.

I view supervision as a collaborative, reflective endeavour that enriches our collective understanding of clinical practice. It's an opportunity to challenge stereotypes, ensure patient safety, and elevate ADHD patient assessment and care. This process involves refining communication, embracing feedback, and fostering empathy.

I recognise the importance of supporting fellow clinicians in their professional journeys, and my passion for ADHD drives me to promote mutual learning and shared enthusiasm within the clinical team.

This process entails refining communication styles, challenging stereotypes, adhering to evidence-based practices endorsed by seasoned experts, and consistently prioritising patient safety. It extends to elevating ADHD patient assessment and ongoing clinical care to the utmost standards. The setting ensures a secure space for posing inquiries and cultivating the capacity to gracefully accept both praise and constructive critique. A core focus lies in channelling empathy and meaningful contributions.

I keenly acknowledge the significance of early, appropriate support in a clinician's professional journey. My fervour for ADHD is profound, and I aspire to collaborate harmoniously with all clinical team members, fostering mutual learning and the dissemination of this passion.